English
Levothyroxine for horses is a synthetic form of thyroxine, a thyroid hormone involved in regulating metabolism, energy use, and many other body systems. Although levothyroxine is approved for veterinary management of hypothyroidism, advances in equine medicine have shown that true hypothyroidism is rare in horses. [1][2]
Today, levothyroxine is more commonly discussed in horses for its role in supporting weight loss and insulin regulation as part of a broader management plan for obesity and metabolic dysfunction. In these cases, the goal is typically not to replace deficient thyroid hormone production, but to support metabolic management alongside dietary control, exercise, and veterinary monitoring. [2][3][4]
Because thyroid hormones influence metabolism, cardiovascular function, and other physiologic processes, levothyroxine can have widespread effects in the horse’s body. Understanding how this medication works, when it may be appropriate, and what risks require monitoring can help owners make informed decisions with their veterinarian. [1][2]
Keep reading to learn how levothyroxine is used in horses, how it affects the endocrine system, and what owners should know about safety, monitoring, side effects, interactions, and competition rules.
Levothyroxine for Horses
Levothyroxine sodium is a synthetic form of thyroxine (T4), one of the two primary hormones produced by the thyroid gland. The thyroid gland consists of two lobes located along the trachea and functions as part of the hypothalamic-pituitary-thyroid (HPT) axis, a regulatory system that controls thyroid hormone production and secretion. [5]
In healthy horses, the hypothalamus releases thyrotropin-releasing hormone (TRH), which stimulates the pituitary gland to produce thyroid-stimulating hormone (TSH). TSH then stimulates the thyroid gland to synthesize and release T4 and smaller amounts of triiodothyronine (T3). Circulating thyroid hormones subsequently suppress further TRH and TSH release. [5]
Levothyroxine provides a supplemental source of T4. Following administration, T4 is converted within tissues to T3, the biologically active thyroid hormone responsible for most thyroid-related cellular effects. [5]
In simpler terms, levothyroxine gives the horse an additional source of thyroid hormone precursor. The body can then convert this hormone into the active form used by cells.
In most mammals, clinical signs associated with low thyroid hormone production (hypothyroidism) include:
- Obesity or difficulty losing weight
- Fatigue or lethargy
- Cold intolerance
- Poor hair coat or hair loss
- Slow heart rate
- Reduced exercise tolerance
- Delayed growth or poor development in young animals
- Reproductive problems
Given this, levothyroxine has historically been administered to horses who have similar signs and a presumptive diagnosis of hypothyroidism. However, advances in equine medicine have demonstrated that hypothyroidism in adult horses is rare. [2][3]
Current evidence supports use of levothyroxine for horses as an adjunct treatment for Equine Metabolic Syndrome (EMS), obesity, and insulin resistance. [2][3]
Available Forms
Equine-specific levothyroxine products are commonly available as oral powders intended for administration with feed. [1]
Common trade names used in equine medicine include:
- Thyro-L®
- ThyroKare™ Equine Powder
- ThyroVet™
Veterinarians may also obtain liquid or injectable formulations through licensed veterinary compounding pharmacies.
What's your top priority with your horse's health?
What's your top priority with your horse's health?
Drug Class: Thyroid Hormone Replacement Agents
Levothyroxine belongs to the class of medications known as thyroid hormones or thyroid hormone replacement agents. [1]
Thyroid hormones help regulate how quickly cells use energy. They influence many body systems, including the heart, muscles, nervous system, digestive tract, skin, and reproductive system. Thyroid hormones also support normal growth and development in young animals. [5]
Other synthetic thyroid hormone preparations include: [1]
- Thyroxine (T4)
- Triiodothyronine (T3)
- Combination thyroid hormone products
Although T4 is the primary hormone secreted by the thyroid gland, T3 is considered the principal biologically active hormone at the cellular level. Within tissues, specialized enzymes known as deiodinases convert T4 into T3 or inactive metabolites depending on physiologic requirements. [5]
Because these hormones affect metabolism throughout the body, abnormal thyroid function can have wide-ranging effects. Too little thyroid hormone may slow normal body processes, while too much thyroid hormone activity can increase metabolic demand and affect heart rate, body condition, and behavior. [5]
Mechanism of Action
Levothyroxine works by supplementing circulating T4 concentrations. After administration, T4 enters target tissues and is converted to T3 by deiodinase enzymes. T3 then binds thyroid hormone receptors located within cell nuclei. These receptors function as transcription factors that regulate expression of numerous genes involved in metabolism and cellular activity. [5]
The drug also alters endocrine function through feedback mechanisms. Administration of exogenous levothyroxine raises circulating thyroid hormone concentrations while suppressing thyroid activity. [2][5]
Through receptor-mediated actions, thyroid hormones influence: [5]
- Basal metabolic rate
- Heat production
- Oxygen consumption
- Carbohydrate metabolism
- Fat metabolism
- Protein synthesis
- Growth and maturation
- Cardiovascular function
- Erythropoiesis (red blood cell production)
Thyroid hormones stimulate lipolysis and lipid utilization while also increasing metabolic energy expenditure. T3 promotes oxidation of fatty acids and influences cholesterol and lipoprotein metabolism. [5][6]
Levothyroxine is used in horses to increase metabolic activity. In overweight or metabolically affected horses, it has been associated with reductions in body weight and improvements in insulin sensitivity. [2][4][6]
These effects are relevant for horses with Equine Metabolic Syndrome (EMS), where obesity commonly contributes to metabolic dysfunction and insulin resistance is a defining feature of the syndrome.
Research evaluating healthy horses found that levothyroxine administration increased circulating thyroid hormone concentrations and improved measures of insulin sensitivity. It also decreased blood lipid concentrations, reduced body weight, and improved measures of insulin sensitivity, although long-term work noted that diet or season may have influenced some findings. [6][7]
Uses in Horses
The only FDA-approved use of levothyroxine in horses is for treatment of documented thyroid hormone deficiency. [1] However, adult-onset hypothyroidism appears to be rare in horses. Diagnostic evaluation can be challenging because numerous factors influence thyroid hormone concentrations, including illness, age, nutrition, and other endocrine conditions. [5]
Accurate diagnosis requires interpretation of thyroid hormone concentrations alongside dynamic endocrine testing when appropriate. [5]
Other uses of levothyroxine in horses are considered extra-label, also referred to as off-label. Extra-label use occurs when a veterinarian prescribes a medication in a manner not specifically described on the approved product label.
Off-Label Uses
Off-label use is permitted under veterinary prescribing regulations when no approved equine alternative is available. In these cases, veterinarians rely on published research, clinical experience, and established treatment protocols to determine appropriate dosing and monitoring.
The clearest clinical rationale for levothyroxine use in horses is to support multimodal management of EMS, obesity, and insulin dysregulation. [2][3][4]
This condition is commonly associated with: [3]
- Excess body condition
- Localized fat accumulation, such as a cresty neck or fat pads around the tailhead
- Abnormal insulin regulation
- Elevated circulating insulin concentrations
- Increased risk of laminitis
Historically, EMS was thought to be caused by hypothyroidism because affected horses often gain weight easily and may have low resting thyroid hormone concentrations. However, subsequent research has shown that low thyroid hormone concentrations are generally a consequence of EMS-related metabolic dysfunction, rather than an underlying cause. [3]
Hyperinsulinemia & Insulin Sensitivity
Sustained hyperinsulinemia (excess circulating insulin) commonly occurs in horses with EMS and is associated with an increased risk of laminitis. Horses with EMS often exhibit exaggerated insulin responses following consumption of dietary sugars and starches. [3][4]
Treatment goals for hyperinsulinemia focus on: [2][3][4]
- Reducing body weight
- Improving insulin sensitivity
- Lowering circulating insulin concentrations
- Decreasing laminitis risk
Levothyroxine may assist in achieving these goals through its metabolic effects and its association with weight loss and improved insulin sensitivity. [2][4]
Research evaluating levothyroxine administration demonstrated significant improvement in insulin sensitivity in treated horses. Enhanced insulin sensitivity may help reduce the metabolic abnormalities associated with obesity and EMS. [2][6]
Weight Management
Studies evaluating levothyroxine administration in healthy adult horses demonstrated significant reductions in body weight during treatment, suggesting potential benefits for obese horses requiring weight loss support. [6][7]
Weight management requires a multimodal approach, including dietary modifications and exercise. Levothyroxine is generally used as one component of a broader treatment program rather than as a sole therapy. [2][3]
Administration Routes
Levothyroxine is administered orally in horses. [1]
Most equine uses of levothyroxine, including treatment of EMS, obesity, and insulin dysregulation, are extra-label. Specific treatment protocols are determined by the attending veterinarian based on the horse’s condition, metabolic status, body condition, and response to therapy. [1][2]
Successful treatment depends on integration of medication with appropriate dietary management and exercise. Calorie restriction, reduction of dietary sugar and starch intake, and controlled physical activity remain essential components of management for horses with EMS. [2][3][4]
Storage
Levothyroxine products should be stored according to manufacturer recommendations and protected from environmental conditions that may affect stability.
Some liquid formulations require refrigeration, and levothyroxine may exhibit reduced stability in aqueous preparations. [1]
Safety Warnings & Precautions
Levothyroxine influences multiple endocrine, metabolic, and cardiovascular processes and should only be administered under veterinary supervision. [1][5][8]
Thyroid hormones affect: [5]
- Oxygen consumption
- Heat production
- Fat metabolism
- Glucose metabolism
- Cardiovascular function
- How the body uses energy
Given this, excessive thyroid hormone exposure may have widespread physiologic consequences. [5]
Historically, levothyroxine was frequently prescribed because obesity, regional adiposity, and laminitis were believed to result from hypothyroidism. More recent research has demonstrated that these conditions are more appropriately classified within EMS and insulin dysregulation syndromes. As a result, treatment should target the underlying metabolic disorder rather than presumed thyroid hormone deficiency alone. [2][3][4]
Because levothyroxine can increase appetite, horses receiving treatment for EMS may require stricter dietary management to maintain weight management goals. Grazing and access to calorie-dense feeds may need to be restricted according to the treating veterinarian’s recommendations. [1][2]
Long-term administration suppresses natural thyroid hormone production through negative feedback mechanisms. If treatment with levothyroxine is stopped, gradual tapering off of the medication may be recommended to ensure healthy thyroid hormone production is recovered. [2]
Levothyroxine use has also been evaluated in actively training Standardbred racehorses. In that trial, higher doses of levothyroxine increased heart rates during exercise and recovery, and half of the horses studied developed cardiac arrhythmias, including atrial fibrillation. These findings support careful veterinary oversight when levothyroxine is used in athletic horses. [8]
Monitoring
Monitoring during levothyroxine treatment focuses on clinical response and endocrine status. [1]
Veterinarians may assess: [1][2]
- Body weight
- Body condition score
- Regional adiposity
- Appetite
- Activity level
- Behavioral changes
- Serum thyroid hormone concentrations
- Indicators of insulin regulation
- Cardiovascular parameters when appropriate
In horses receiving levothyroxine for EMS, reductions in body weight and improvements in insulin regulation are important therapeutic objectives. [2][3][4]
Measurement of thyroid hormone concentrations may be useful during treatment, particularly during prolonged administration. Interpretation of results should take into account the suppressive effects of levothyroxine on the horse’s natural thyroid hormone production. [1][2][5]
Contraindications
Contraindications refer to circumstances where a drug should be avoided or used with caution.
Levothyroxine should be used cautiously in horses where increased thyroid hormone activity could worsen cardiovascular or systemic instability. [1][5][8]
Because administration suppresses internal thyroid hormone production, prolonged treatment requires ongoing veterinary supervision. [2][5]
The drug should not be administered to horses with known hypersensitivity to components of the formulation. [1]
Side Effects
The effects associated with levothyroxine administration generally reflect increased thyroid hormone activity and elevated metabolic rate. [1][2][7]
Potential effects associated with increased thyroid hormone activity may include: [1][2]
- Increased appetite
- Increased activity
- Mild hyperexcitability
- Behavioral changes
- Alterations in metabolic rate
Increased appetite is particularly relevant when levothyroxine is administered to horses with EMS or obesity because increased feed consumption may interfere with weight loss goals. Careful dietary management remains important for the entire course of treatment. [2]
Research evaluating healthy adult horses also documented cardiac changes during prolonged treatment. Although measurable echocardiographic effects were observed, the reported findings were not considered clinically important in the horses studied. [7]
Acute Toxicity (Overdose)
Information regarding acute levothyroxine overdose in horses is limited. [1]
Excessive administration is expected to produce signs consistent with excessive thyroid hormone activity and marked metabolic stimulation.
Potential reactions may include: [1]
- Marked hyperactivity
- Excessive excitability
- Increased heart rate
- Increased metabolic demand
- Gastrointestinal disturbances
Because thyroid hormones affect multiple organ systems, suspected overdose warrants prompt veterinary guidance. [1]
Owners should contact their veterinarian immediately if a horse receives an accidental overdose or develops concerning clinical signs following administration. Prompt veterinary evaluation is also warranted if severe behavioral changes, cardiovascular abnormalities, or other unexpected reactions occur during treatment. [1]
Drug Interactions
Levothyroxine may interact with medications, supplements, and compounds that influence thyroid hormone absorption, metabolism, distribution, or physiologic activity. [1] A complete medication and supplement history should be reviewed before initiating treatment. [1]
Potential interactions include: [1]
- Antacids
- Calcium-containing products
- Iron supplements
- Sucralfate
- Estrogen-containing products
- Phenobarbital
- Glucocorticoids (steroids)
- Ketamine
- Tricyclic antidepressants
Some products may reduce gastrointestinal absorption of levothyroxine, while others may alter thyroid hormone metabolism or physiologic responsiveness. This means concurrent administration of multiple medications may affect treatment outcomes. [1]
Glucocorticoids (steroids) are particularly relevant in horses because they can decrease insulin sensitivity and influence glucose regulation. Since insulin dysregulation plays a central role in EMS, veterinarians should carefully consider concurrent therapies when managing affected horses. [5]
Injectable levothyroxine formulations should not be mixed with other medications or intravenous fluids unless compatibility has been established. [1]
Regulatory Status & Legal Considerations
Levothyroxine is approved for use in horses for documented thyroid hormone deficiency, but use for EMS, obesity, insulin dysregulation, or laminitis risk is extra-label.
In those cases, it is used under veterinary direction as part of multimodal management that may also include dietary management, exercise, and ongoing monitoring. [1][2][3][4]
Status in Competition
Levothyroxine treatment is regulated by most competitive organizations, including the Fédération Equestre Internationale (FEI). [9]
Under FEI rules, substances are classified as either banned or as controlled medications. Levothyroxine is considered a controlled medication, meaning it is a therapeutic drug permitted out of competition but prohibited in-competition unless properly declared.
Detection times and withdrawal periods can vary depending on the dosage, duration of use, and the specific regulatory body governing your competition. You should always consult with your treating veterinarian to ensure an adequate safety margin is applied prior to testing. Always check the regulations for your sport before starting a new medication for your horse.
Frequently Asked Questions
Here are some frequently asked questions about levothyroxine for horses:
Levothyroxine is used in horses as a synthetic thyroid hormone medication, most often as part of a broader management program for Equine Metabolic Syndrome (EMS), obesity, and insulin dysregulation. Although its only FDA-approved equine use is treatment of documented thyroid hormone deficiency, adult-onset hypothyroidism appears to be uncommon in horses. In current practice, levothyroxine is more commonly used off-label to support weight loss and improve metabolic regulation under veterinary supervision.
Levothyroxine can help some horses lose weight when it is used as part of a complete weight-management program. Research has associated levothyroxine administration with reductions in body weight and improved measures of insulin sensitivity. However, levothyroxine is not a stand-alone weight-loss solution; dietary control, appropriate exercise, and regular monitoring remain essential for horses with EMS or obesity.
Levothyroxine works in horses by providing a supplemental source of thyroxine, also known as T4. After administration, T4 is converted in tissues to triiodothyronine, or T3, the more biologically active thyroid hormone. T3 influences gene expression and affects metabolism, energy use, fat metabolism, heat production, oxygen consumption, and cardiovascular function throughout the body.
Levothyroxine can improve measures of insulin sensitivity in some horses. Research has shown improvements in insulin sensitivity during levothyroxine administration, which may be useful for horses with insulin dysregulation. Improved insulin regulation is one reason the medication may be included in EMS management, but it should still be paired with dietary restriction, exercise, and veterinary monitoring.
Levothyroxine is approved for treating documented thyroid hormone deficiency in horses, but true hypothyroidism is very rare in adult horses. Many horses once suspected of having hypothyroidism because of obesity, laminitis, or poor performance are now understood to have EMS or other metabolic disorders. Accurate diagnosis requires careful interpretation of thyroid hormone testing, because age, illness, nutrition, and other endocrine conditions can affect thyroid hormone concentrations.
Levothyroxine may help reduce factors associated with laminitis risk when it improves weight management and insulin regulation in horses with EMS. Sustained high insulin levels are associated with increased risk of endocrinopathic laminitis, so improving insulin sensitivity is an important treatment goal. Levothyroxine should not be viewed as a direct laminitis treatment or prevention guarantee; it is one part of a broader metabolic management plan.
Levothyroxine side effects in horses generally reflect increased thyroid hormone activity and a higher metabolic rate. Potential effects include increased appetite, increased activity, mild hyperexcitability, behavioral changes, and changes in metabolic rate. Increased appetite can be especially important in horses treated for EMS or obesity because extra feed intake can interfere with weight-loss progress.
Levothyroxine can affect a horse's heart because thyroid hormones influence cardiovascular function. In actively training Standardbred racehorses, higher-dose levothyroxine supplementation was associated with increased heart rates during exercise and recovery, and some horses developed cardiac arrhythmias, including atrial fibrillation. Athletic horses and horses with cardiovascular concerns should be managed carefully by a veterinarian when levothyroxine is used.
How long a horse can stay on levothyroxine depends on the horse's condition, treatment goals, response to therapy, and veterinary monitoring results. Long-term administration can suppress the horse's normal hypothalamic-pituitary-thyroid axis through negative feedback. When treatment is discontinued, gradual tapering may be recommended to support recovery of normal thyroid-axis activity.
Monitoring while a horse is taking levothyroxine should include both clinical response and endocrine status. Veterinarians may track body weight, body condition score, regional fat deposits, appetite, activity level, behavior, thyroid hormone concentrations, and indicators of insulin regulation. Cardiovascular monitoring may also be appropriate in some horses, especially athletic horses or those showing abnormal heart rate, exercise intolerance, or other concerning signs.
Levothyroxine is not automatically safe for all horses and should only be used under veterinary supervision. It should be used cautiously when increased thyroid hormone activity could worsen cardiovascular or systemic instability. Horses with known hypersensitivity to ingredients in the formulation should not receive the medication, and all horses on prolonged treatment should be monitored for metabolic, endocrine, and behavioral effects.
Levothyroxine can interact with medications, supplements, and compounds that affect thyroid hormone absorption, metabolism, distribution, or physiologic activity. Potential interactions include antacids, calcium-containing products, iron supplements, sucralfate, estrogen-containing products, phenobarbital, glucocorticoids, ketamine, and tricyclic antidepressants. Horse owners should tell their veterinarian about all prescription drugs, over-the-counter products, supplements, and nutritional additives before starting levothyroxine.
If an excessive dose of levothyroxine has been administered to your horse, contact a veterinarian promptly for guidance. Information on acute levothyroxine overdose in horses is limited, but excessive thyroid hormone exposure may cause marked hyperactivity, excessive excitability, increased heart rate, increased metabolic demand, or gastrointestinal disturbances. Immediate veterinary advice is especially important if the horse develops severe behavioral changes, cardiovascular abnormalities, or other unexpected reactions.
Levothyroxine use in horse competitions depends on the rules of the governing organization. Under FEI rules, levothyroxine is considered a controlled medication, meaning it is permitted out of competition but prohibited in competition unless properly declared. Detection times and withdrawal guidance can vary by dose, duration of use, and sport organization, so owners should consult their veterinarian and check current competition rules before using it in a competing horse.
Summary
Levothyroxine is a synthetic thyroid hormone used in horses under veterinary direction. Although approved for thyroid hormone deficiency, it is more commonly used off-label as part of broader management for EMS, obesity, and insulin dysregulation.
- Levothyroxine provides supplemental T4, which can be converted into active T3 by body tissues
- Adult-onset hypothyroidism is considered rare in horses, so diagnosis requires careful veterinary evaluation
- Off-label use may support weight loss and insulin sensitivity in horses with EMS or obesity
- Treatment should be paired with dietary control, exercise, and ongoing monitoring
- Possible side effects include increased appetite, activity changes, hyperexcitability, and cardiovascular effects
- Competition horses may be subject to medication rules and withdrawal guidance
References
- Budde. J. A. et al. Eds. Plumb's Veterinary Drug Handbook. 10th edition. Educational Concepts, LLC, dba VetMedux, Tulsa, OK. 2023.
- Cole. C. et al. Eds. Equine Pharmacology. Wiley Blackwell, Ames, Iowa. 2015.
- Frank. N. Equine Metabolic Syndrome. Journal of Equine Veterinary Science. 2009. doi: 10.1016/j.jevs.2009.04.183.
- Durham. A. E. Therapeutics for Equine Endocrine Disorders. Veterinary Clinics of North America: Equine Practice. 2017.
- Reed. S. M. et al. Equine Internal Medicine. 3rd ed. Saunders Elsevier, St. Louis, Mo. 2010.
- Frank. N. et al. Effects of Oral Administration of Levothyroxine Sodium on Concentrations of Plasma Lipids, Concentration and Composition of Very-Low-Density Lipoproteins, and Glucose Dynamics in Healthy Adult Mares. American Journal of Veterinary Research. 2005.
- Frank. N. et al. Effects of Long-Term Oral Administration of Levothyroxine Sodium on Glucose Dynamics in Healthy Adult Horses. American Journal of Veterinary Research. 2008. View Summary
- Kritchevsky. J. et al. A Randomised, Controlled Trial to Determine the Effect of Levothyroxine on Standardbred Racehorses. Equine Veterinary Journal. 2022. View Summary
- 2026 Equine Prohibited Substances List. FEI. 2025.
